Cryptococcus  by McDonald, Tami et al.
Current Biology Vol 22 No 14
R554
the ‘machine level’ language of life is 
and remains chemistry. We have to 
preserve our fluency in chemistry in 
the pursuit of our long-term dream of 
understanding biology and of curing 
disease. We need good chemical gear 
to avoid that the study of phenotypes 
remains an exercise of cartography 
at low-resolution. If potential targets 
for cures are identified, we need to 
remember that we cannot reach their 
summit in a T-shirt and sneakers, and 
without a good map and solid testable 
hypotheses. 
What are you arguing? For instance, it 
may seem paradoxical that while we are 
gaining more information on the genetic 
landscape of cancer, the search for 
new anti-cancer drugs is suffering an 
implosion, generating what is hopefully 
an only temporary disillusion in our 
abilities to achieve something useful in 
the domain of cures. 
Too much emphasis put on the 
identification of new potential targets 
might divert us from the goal of 
developing better weapons against the 
old ones, many of which are validated 
and recurrent. We might need to admit 
our dramatic ignorance of mechan-
isms, accept it as a basis for our 
temporary failures, and invest more in 
them. New targets, and new theories, 
are not necessarily better or more 
promising than the old ones. 
Let’s close with more mundane 
thoughts: how did you get into 
biology? In the last year of high school 
one of my teachers introduced me to 
the relationship between the literary 
work of Giacomo Leopardi and the 
modern philosophical implications 
of the theory of evolution discussed 
in Monod’s Chance and Necessity. 
Leopardi was an Italian poet of 
pessimistic inspiration who lived in 
the first third of the 19th century and 
who portrayed Nature as a distant 
stepmother, rather than a caring 
mother. From his literary observatory, 
he deconstructed and demystified 
the human position in the universe 
without having available the rational 
justifications later provided by 
evolutionary theory. 
After high school, I enrolled in the 
faculty of Literature and Philosophy in 
Rome, but after two and a half years 
and a feeling of dissatisfaction, I finally 
told myself that I could dare being a 
scientist even if I had never thought 
seriously about it. So I started studying 
biology, which in Italy, where disciplines 
are rather strictly confined, implied a 
change of faculty. Essentially, I found 
myself back to square one. My new 
‘me’ had to do a lot of hard work to 
compensate for its basic ignorance of 
scientific matters, but I kept going until 
I was accepted as an undergraduate 
in the laboratory of Gianni Cesareni, 
working with Manuela Helmer-Citterich, 
Franco Felici, and Luisa Castagnoli. 
Looking back to those years, I 
recognize that it was my great chance 
in life. I was ignorant of the world and 
needed help to visualize my options. 
That is precisely the help that Gianni 
offered, careless of his own interest. 
I owe him for this and for the many 
other things I received in his laboratory. 
Almost 25 years later, I try to abide by 
the same principles in my laboratory. 
What happened next? Cesareni had 
foreign visitors one day and as we 
were going out for a social event 
he realized that I could more or less 
frame a sentence in English. Two days 
later he suggested that I should try the 
selections for the PhD program of the 
EMBL. I wrote my application and was 
invited to participate in the selection. 
It was 1990. I remember boarding a 
train in Rome, directed to Heidelberg, 
in a most reluctant mood, certain that 
I would fail and that, anyway, getting 
into that program was the last thing I 
wanted. Upon arriving in Heidelberg, 
it took me less than two hours to 
change my mind. The only thing I 
wanted now was to get into that PhD 
program. And so it was. I started 
working with Matti Saraste, who died 
tragically in 2001. Those who have 
met Matti and worked with him are 
still overcome with sadness when they 
think about his end. 
I left Heidelberg in 1995 to work 
with Stephen C. Harrison at the 
Harvard Medical School. Steve had 
an impressive lab; I felt surrounded 
by fantastic people who were not 
afraid of tackling the most complex 
crystallographic problems I had seen 
until then. It was an eye-opener that 
has influenced every aspect of my 
subsequent experience. 
And then? Then I tried to return to 
Italy, but that’s another story. 
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What is Cryptococcus? Cryptococcus 
is a yeast that is surrounded by a thick 
coating of polysaccharides, called 
a capsule (Figure 1); for this reason 
Cryptococcus is often referred to as 
‘the sugar yeast’.
A sugar yeast — sounds great for 
making beer, bread and wine! No, 
that’s not Cryptococcus. ‘Yeast’ is a 
catch-all term for any single-celled 
fungus, so many unrelated fungi 
can be called yeasts. The common 
kitchen yeast exploited by humankind 
for millennia to ferment the sugars 
in food into alcohol and CO2 is 
actually Saccharomyces cerevisiae, 
an ascomycete. The Cryptococcus 
species were initially misclassified as 
Saccharomyces when two scientists 
independently discovered the fungus at 
the end of the 19th century. Sanfelice, 
a Sardinian, serendipitously isolated 
yeasts from aging peach juice. Yet his 
discovery was not the early precursor 
to the Bellini cocktail, because the 
German Busse simultaneously isolated 
the encapsulated yeast from a patient 
presenting with an unknown mycosis.
Cryptococcus is actually a 
basidiomycete yeast, more closely 
related to the mushrooms on your 
pizza than the yeast used to leaven 
the crust or to ferment the beer you 
drink with it. The early work by Busse 
suggesting that Cryptococcus could be 
a novel fungal pathogen was confirmed 
by subsequent animal pathogenesis 
experiments proving Koch’s postulates 
that set the foundation for a century of 
productive research.
Thick hair, tanned flesh, buxom 
body, and a robust libido… a 21st 
century popular icon? These terms 
are not describing the latest reality 
TV star; rather, they are the known 
virulence factors of Cryptococcus, its 
polysaccharide capsule, melanin, cell 
enlargement, and sexual reproduction. 
The thick sugary polysaccharide 
capsule allows the yeast to evade the 
host immune response by resisting 




Figure 1. Micrograph of Cryptococcus cells 
stained with india ink.
The polysaccharide capsule is visible as a 
zone of clearing around the cell body. Two 
normal size cryptococcal cells have been 
phagocytosed by host cells. In contrast, the 
titan cells are too large to be phagocytosed.
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The phenomenon of endosymbiosis, 
or one organism living within another, 
has deeply impacted the evolution 
of life and continues to shape the 
ecology of countless species. 
Traditionally, biologists have viewed 
evolution as a largely bifurcating 
pattern, reflecting mutations and other 
changes in existing genetic information 
and the occasional speciation and 
divergence of lineages. While lineage 
bifurcation has clearly been important 
in evolution, the merging of two 
lineages through endosymbiosis has 
also made profound contributions to 
evolutionary novelty. Mitochondria 
and chloroplasts are relicts of ancient 
bacterial endosymbionts that ultimately 
extended the range of acceptable 
habitats for life by allowing hosts to 
thrive in the presence of oxygen and 
to convert light into energy. Today, the 
sheer abundance of endosymbiotic 
relationships across diverse host 
lineages and habitats testifies to their 
continued significance.
Endosymbionts and their hosts often 
represent distinct domains of life. As a 
consequence, their amalgamation can 
generate entirely new combinations 
of biochemical capabilities and 
allow the two, intertwined species 
to thrive in environments that would 
be inhospitable to either alone. For 
example, these intimate relationships 
often involve a bacterial endosymbiont 
living within a eukaryotic host. From 
an evolutionary standpoint, bacteria 
had a couple billion-year head start on 
eukaryotes. Not surprisingly, bacteria 
invented many biochemical processes 
that are central to ecosystem 
functioning. These include the only 
known forms of primary energy 
production — photosynthesis and 
chemosynthesis — as well as key 
mechanisms of nutrient recycling, such 
as nitrogen fixation. Eukaryotes are 
able to perform these functions only 
by virtue of their ancient or current 
endosymbiotic associations with 
bacteria (or, more rarely, with archaea). 
The most comprehensive definition 
of endosymbiosis includes the full 
spectrum of interaction types, from 
harmful (parasitic) to beneficial 
Primerdegradation by phagocytes (Figure 1). 
Polysaccharide that has dissociated 
from the cell also inhibits T-cell and 
cytokine responses, and this curious 
property has prompted investigation 
into using purified Cryptococcus 
capsule as a potential therapy for some 
forms of autoimmunity. Embedded 
in the cell wall, directly below the 
sugar coat, resides a pigment, 
melanin, that is capable of scavenging 
oxygen radicals deployed by host 
cells, thereby preventing oxidative 
damage and promoting survival 
inside phagocytes. The pigment can 
also bind to conventional fungicides 
and reduce drug efficacy. When the 
yeast is growing in the environment, 
melanin confers a fitness advantage by 
permitting the fungus to grow at wide 
temperature ranges, survive in high 
concentrations of toxic metals, and 
resist ionizing radiation. 
Cryptococcus also forms gigantic 
cells dubbed ‘titan cells’, which are 
too large for phagocytes to engulf 
(Figure 1), are able to protect normal 
cryptococcal cells from the host 
immune response, and play a key role 
in establishment of disease. Finally, 
one of the sexes (the a mating type) 
is more prevalent in both the 
environment and the clinic. The a 
cells are bisexual — they undergo 
heterosexual mating with the opposite 
mating type, but are also homosexual, able to propagate by same-sex 
mating. These traits collectively 
distinguish Cryptococcus from many 
other human pathogens.
Can Cryptococcus make you sick? 
Yes and no. Cryptococcus is found in 
the environment, in and on things we 
are exposed to often. Been to a city 
park? You’ve probably been exposed to 
Cryptococcus. Cryptococcus can live in 
pigeon droppings, in soil, on trees, and 
in other environmental reservoirs not 
yet fully defined. Normally, your immune 
system fights the cryptococcal infection 
and you may never know you have 
been exposed. But Cryptococcosis is 
recognized as an emerging infectious 
disease. Cryptococcus gattii can infect 
and cause disease in otherwise healthy 
individuals. More than 200 people 
have acquired C. gattii infections in 
the North American Pacific Northwest 
in an outbreak that is spreading south 
down the Pacific coast. In addition, 
Cryptococcus neoformans significantly 
burdens immunocompromised 
populations — mainly organ transplant 
patients on immunosuppressants and 
persons living with HIV/AIDS. More than 
a million new cases of C. neoformans 
are reported annually in persons 
infected with HIV, and even with the 
availability of anti-retroviral and anti-
fungal therapies, the rate of survival is 
less than 40%. 
Cryptococcal meningitis has 
surpassed tuberculosis as the most 
lethal opportunistic infection of AIDS 
patients in Africa. Roughly half the 
people that survive this meningitis 
are often confronted with additional 
complications during immune 
recovery. Patients can experience a 
clinical relapse of aseptic meningitis 
and non-central nervous system 
inflammation that can result in death. 
By and large, the general public need 
not fear infection, but cryptococcosis 
remains an important public health 
concern in specific regions of the 
world. 
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